The Minnesota Department of Health (MDH) supports the inclusion of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) as an evidence-based intervention to prevent HIV transmission. The primary goal of PrEP is to reduce new HIV transmission among people who are at a high risk for acquiring HIV and continues efforts to increase access to these lifesaving interventions and reduce new HIV infections in the state.
Pre-Exposure Prophylaxis (PrEP): The daily use of an antiretroviral medication (tenofovir/emtiricitabine, brand name Truvada) to prevent HIV infection by uninfected persons.
Post-Exposure Prophylaxis (PEP): Taking antiretroviral medications after an HIV exposure to reduce the chances of becoming infected. This is also referred to as nPEP, for non-occupational post-exposure prophylaxis.
We are compiling a voluntary directory of PrEP/PEP providers. Please fill out this survey to be listed on the MDH website.
Questions marked with an asterisk (*) are required.
I understand that participation in this public directory is voluntary. I understand that by sharing the information above, I am agreeing to have this information be publicly listed on the MDH website (with the exception of the contact name and email address). I understand that inclusion in this directory does not confer any endorsement by MDH nor does it establish MDH credentialing or certification in a specialty.